The Rise and Fall of Monashee Investment Management LLC: A Comparison of Q3 and Q4 2022 Holdings

Investing is a tricky business, and staying on top of your holdings can be a challenge. As we move into the final quarter of 2022, many investors are looking back on the previous months to assess their progress and make any necessary changes to their portfolios. One of those investors is Monashee Investment Management LLC, and their Q3 2022 and Q4 2022 13F holdings comparison reveals some interesting trends.

In this blog post, we'll take a closer look at Monashee Investment Management LLC and examine their portfolio changes from Q3 to Q4 of 2022. We'll explore some of the top holdings, identify any significant changes, and consider what these changes might mean for the future.

Overview of Monashee Investment Management LLC

Monashee Investment Management LLC is a New York-based investment management firm that primarily invests in the healthcare sector. The firm was founded in 2012 by Dan Baker, a former healthcare analyst at Third Point LLC. Monashee Investment Management LLC manages over $300 million in assets and has a well-established reputation for its expertise in the healthcare industry.

Top Holdings

Monashee Investment Management LLC's portfolio includes a diverse range of holdings, but some companies stand out as the top holdings. In Q3 2022, the top holding was Vanguard Index Fds (VTI), which made up over 22% of the portfolio. Other top holdings included Invesco QQQ Tr (QQQ), Novavax Inc, and Patrick Inds Inc.

In Q4 2022, Monashee Investment Management LLC made some significant changes to its holdings. Vanguard Index Fds (VTI) was no longer the top holding, having been replaced by Novavax Inc., which made up nearly 25% of the portfolio. Other top holdings in Q4 included RingCentral Inc., Western Digital Corp., and Illumina Inc.

Significant Changes

Perhaps the most notable change in Monashee Investment Management LLC's holdings is the significant increase in the number of shares of Novavax Inc. The company had zero shares in Q3 2022 but held nine million shares in Q4. This increase in exposure to Novavax Inc. is likely due to the company's success in vaccine development amid the COVID-19 pandemic.

Another interesting change is the decision to add new holdings, such as RingCentral Inc. and Western Digital Corp., while letting go of others. For example, Monashee Investment Management LLC completely sold out of its position in Invesco QQQ Tr (QQQ) in Q4, despite it being a top holding in Q3.

What Do These Changes Mean?

It's not easy to predict the future of any stock or company with complete accuracy. However, Monashee Investment Management LLC's moves in Q4 2022 do reveal some interesting trends. For example, their increased exposure to Novavax Inc. suggests that they believe the company has a promising future in vaccine development.

Furthermore, the changes made to the portfolio also suggest that Monashee Investment Management LLC is keeping a close eye on the tech industry. Both RingCentral Inc. and Western Digital Corp. are tech companies that have seen significant growth in recent years, and Monashee Investment Management LLC's decision to add them to their holdings may indicate that they think their success will continue.

Conclusion

Monashee Investment Management LLC's Q3 2022 and Q4 2022 13F holdings comparison reveals some fascinating trends. The firm has made significant changes to its portfolio, including adding new holdings and increasing its exposure to Novavax Inc. These changes suggest that Monashee Investment Management LLC is keeping a close eye on the healthcare and tech industries and believes that these companies have a promising future. While it's impossible to predict the future of any stock or company with complete accuracy, Monashee Investment Management LLC's portfolio changes provide a glimpse into their investment strategy and goals for the future.